FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA on Pharmacodynamic Biomarker Research

FDA outlines research into potential pharmacodynamic biomarkers for biosimilar development.

latest-news-card-1
Federal Register

Docket Open for Opioids Home Disposal REMS

Federal Register notice: FDA establishes a docket to obtain information and comments to help assess whether in-home disposal products can be expected ...

latest-news-card-1
Human Drugs

FDA Selecting Fall Covid Vaccine Make-up in June

CBER director Peter Marks says Covid-19 vaccine makers will be given advice in June on the next booster vaccine composition for fall injections.

latest-news-card-1
Human Drugs

Phathom Plans to Resubmit NDA, and Supplemental NDA

Phathom Pharmaceuticals says it will resubmit an NDA for vonoprazan for treating erosive esophagitis, and a post-approval supplement for Voquezna Trip...

latest-news-card-1
Human Drugs

2 Pfizer sNDA Submitted for Lung Cancer Drugs

FDA accepts for review two Pfizer Supplemental NDAs for Braftovi (encorafenib) and Mektovi (binimetinib) and their use in patients with metastatic non...

latest-news-card-1
Human Drugs

OCP IND Prioritization, Triage Guidance

CDER issues an updated MAPP for Office of Clinical Pharmacology IND review processes.

latest-news-card-1
Animal Drugs

Guide on Animal Drug Human Safety Assessments

FDA posts a draft guidance entitled Human User Safety in New and Abbreviated New Animal Drug Applications to inform sponsors of the types of informati...

Medical Devices

Abbott Safety Notice on FreeStyle Libre Readers

Abbott issues a safety notice for the Readers and batteries used as part of the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash g...

latest-news-card-1
Human Drugs

Tavo-EP/Keytruda Fails Phase 2 Melanoma Trial

OncoSec says its Tavo-EP in combination with Mercks Keytruda failed to meet the overall response rate primary endpoint in a Phase 2 trial with some me...

latest-news-card-1
Medical Devices

Synovo Adulterated, Misbranded Products

FDA warns Fullerton, CA-based Synovo Production about its manufacturing and distribution of adulterated and misbranded orthopedic medical devices.